Consideration of Drug Therapy in Benign Prostatic Hypertrophy

1. Koch, W., Ezz, E. & de Wildt, M. (1996). The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J. Urol. 155(1), 186-189.10.1016/S0022-5347(01)66589-3Search in Google Scholar

2. McConnell, J., Bruskewitz, R. & Walsh, P. (1998). The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. New Engl. J. Med. 338(9), 557-563.10.1056/NEJM199802263380901Search in Google Scholar

3. Barkin, J., Guimaraes, M. & Jacobi, G. (2003). Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5-alphareductase inhibitor dutasteride. Eur. Urol. 44(4), 461-466.10.1016/S0302-2838(03)00367-1Search in Google Scholar

4. Boyle, P. (1994). Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension. Br. J. Clin. Pract. Suppl. 74, 18-22.Search in Google Scholar

5. ⊛⊛⊛⊛⊛AUA (American Urological Association) practice guideline committee. (2004). AUA guidelines on management of benign prostatic hyperplasia. J. Urol. 170(2 Pt 1), 530-54710.1097/01.ju.0000078083.38675.79Search in Google Scholar

6. ⊛⊛⊛⊛⊛American Urological Association. (2004). The management of benign prostatic hyperplasia. Baltimore, USA: American Urological Association, Inc. Publishers.Search in Google Scholar

7. Dahlstrand, C., Walden, M. & Deirsson, G. (1995). Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br. J. Urol. 76(5), 614-618.10.1111/j.1464-410X.1995.tb07788.xSearch in Google Scholar

8. Vesely, S., Knutson, T. & Damber, J. (2003). Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand. J. Urol. Nephrol. 37(4), 322-328.10.1080/00365590310014760Search in Google Scholar

9. Aarnink, R., Beerlage, H. & de la Rosette, J. (1998). Transrectal ultrasound of the prostate: innovations and future applications. J. Urol. 159(5), 1568-1579.10.1097/00005392-199805000-00045Search in Google Scholar

10. Epstein, R., Lydick, E. & de Labry L. (1991). Age-related differences in risk factors for prostatectomy for benign prostatic hyperplasia: the VA Normative Aging Study.Urology. 38(Suppl. 1), 9-12.10.1016/0090-4295(91)80192-ASearch in Google Scholar

11. Andriole, G. & Kirby, R. (2003). Safety and tolerability of the Dual 5 alpha-Reductase Inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur. Urol. 44(1), 82-88.10.1016/S0302-2838(03)00198-2Search in Google Scholar

12. Roehrborn, C., Malice, M. & Cook, T. (2001). Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: A comprehensive analysis of the pooled placebo groups of several large clinical trials. Urology. 58(2), 210-216.10.1016/S0090-4295(01)01155-4Search in Google Scholar

13. Minardi, D., Garafolo, F. & Yehia, M. (2001). Pressure-flow studies in men with benign prostatic hypertrophy before and after treatment with transurethral needle ablation. Urol. Int. 66(2), 89-93.10.1159/00005657711223750Search in Google Scholar

14. O'Rahilly, R. & Miiller, Fabiola. (1996). Human embryology and teratology (2nd ed.). New York, USA: A. John Wiley & Sons, Inc. Publication.Search in Google Scholar

15. Tkocz, M. & Prajsner, A. (2002). Comparison of long-term results of transurethral incision of the prostate with transurethral resection of the prostate, in patients with benign prostatic hypertrophy. Urol. 21(2), 112-116.10.1002/nau.1001311857663Search in Google Scholar